Medicaid

Georgia Medicare AAA Screening SAAAVE Act 2026 Guide

Medicare covers a one-time abdominal aortic aneurysm (AAA) ultrasound screening for eligible beneficiaries through Section 1861(bbb) of the Social Security Act, established by Section 5112 of the

Brevy Care Team

· 38 min read

By Brevy Care Team

Medicare covers a one-time abdominal aortic aneurysm (AAA) ultrasound screening for eligible beneficiaries through Section 1861(bbb) of the Social Security Act, established by Section 5112 of the Deficit Reduction Act of 2005 (Public Law 109-171). This provision is commonly known as the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act. The benefit became effective January 1, 2007. The original SAAAVE Act required referral during the Initial Preventive Physical Examination ("Welcome to Medicare" visit) within 12 months of Medicare Part B enrollment, but the Affordable Care Act (ACA) Section 4103 eliminated the IPPE referral requirement effective January 1, 2011, substantially expanding access. ACA Section 4104 applies the preventive services cost-sharing waiver for USPSTF Grade B aligned screening, making the AAA screening free for eligible beneficiaries.

For Georgia Medicare beneficiaries, AAA screening represents a one-time opportunity to detect a potentially catastrophic vascular condition that is often clinically silent until rupture. AAA rupture is a major cause of cardiovascular mortality with a case-fatality rate approaching 80 percent including out-of-hospital deaths. The risk concentrates strongly in older male smokers, which is the population USPSTF identifies as Grade B for screening. Georgia's smoking prevalence has historically exceeded national averages, particularly in rural counties, making the SAAAVE Act benefit especially relevant to a substantial population of Georgia Medicare beneficiaries. This guide explains the statutory framework, eligibility criteria, HCPCS coding, cost-sharing structure, the ACA Section 4103 IPPE referral elimination that broadened access, the USPSTF recommendation framework across sex and smoking status, the AAA pathophysiology and natural history, surveillance imaging for small aneurysms, endovascular and open surgical repair pathways for larger aneurysms, tobacco cessation coordination, and the Georgia vascular surgery landscape.

Key Takeaways

Statutory authority: Section 1861(bbb) of the Social Security Act provides the AAA screening coverage authority. The benefit was established by Section 5112 of the Deficit Reduction Act of 2005 (Public Law 109-171), known as the SAAAVE Act, signed February 8, 2006 and effective January 1, 2007.
One-time benefit: Medicare covers AAA ultrasound screening once per lifetime. Beneficiaries who receive a covered SAAAVE Act screening are not eligible for an additional one through this benefit.
Eligibility criteria: An eligible beneficiary is one who (a) has a family history of abdominal aortic aneurysm, or (b) is a man age 65 to 75 who has smoked at least 100 cigarettes in his lifetime. The benefit applies to beneficiaries within these criteria when they receive a referral.
HCPCS coding: AAA ultrasound screening is billed under HCPCS G0389. The professional component is the interpretation by the radiologist; the technical component is the ultrasound study at the imaging facility.
IPPE referral originally required, ACA eliminated: The original SAAAVE Act required referral during the Initial Preventive Physical Examination within 12 months of Part B enrollment. ACA Section 4103 eliminated this requirement effective January 1, 2011. Today the referral may come during the IPPE, the Annual Wellness Visit, or any qualified clinical encounter.
ACA cost-sharing waiver: ACA Section 4104 eliminates Part B deductible and coinsurance for USPSTF Grade A and B preventive services. Because USPSTF gives men age 65 to 75 who have ever smoked a Grade B recommendation for AAA screening, this group pays $0 for the screening. Beneficiaries qualifying by family history without smoking history may have cost-sharing depending on USPSTF grade alignment.
USPSTF recommendation framework: Grade B for men age 65 to 75 who have ever smoked. Grade C for men age 65 to 75 who have never smoked (selective offering). Grade I (insufficient evidence) for women age 65 to 75 who have ever smoked. Grade D (recommend against) for women who have never smoked.
Detection and surveillance: AAA is defined as abdominal aortic diameter of 3.0 cm or larger. Aneurysms 3.0 to 5.4 cm typically undergo surveillance imaging at intervals based on size. Aneurysms 5.5 cm or larger, rapidly enlarging, or symptomatic generally warrant referral for repair.
Repair pathways: Two primary repair approaches are endovascular aneurysm repair (EVAR) and open surgical repair. EVAR involves stent-graft placement via femoral artery access. Open repair involves direct surgical replacement of the aneurysmal segment with a synthetic graft.
Georgia landscape: Major Georgia vascular surgery programs include Emory Vascular Surgery, Wellstar Vascular Surgery, Piedmont Heart Institute Vascular Surgery, Northside Hospital Vascular Surgery, Augusta University Vascular Surgery, Atrium Health Navicent Vascular Surgery, and Memorial Health Vascular Surgery (Savannah). Coordination with tobacco cessation is essential through the Georgia Tobacco Quit Line and Medicare cessation counseling.

Part 1: The Statutory and Regulatory Framework

Section 1861(bbb) of the Social Security Act (42 U.S.C. 1395x(bbb)) defines "ultrasound screening for abdominal aortic aneurysm" for purposes of Medicare coverage. The statute defines the service as a procedure to detect an abdominal aortic aneurysm using ultrasound. It establishes that coverage applies to an "eligible beneficiary" who has obtained a referral from a physician, physician assistant, nurse practitioner, or clinical nurse specialist.

The eligible beneficiary definition includes (a) someone with a family history of abdominal aortic aneurysm, or (b) a man age 65 to 75 who has smoked at least 100 cigarettes in his lifetime. This statutory definition of eligibility has remained stable since the original SAAAVE Act provision.

The SAAAVE Act and the Deficit Reduction Act of 2005

The Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act was enacted as Section 5112 of the Deficit Reduction Act of 2005 (Public Law 109-171). The Deficit Reduction Act was signed into law February 8, 2006. The AAA screening benefit became effective January 1, 2007.

The SAAAVE Act represented the first time Medicare covered a screening ultrasound for an asymptomatic vascular condition. It also represented one of the early uses of statutory direction to cover a specific preventive service in the post-MMA era. The MMA (Medicare Modernization Act of 2003, Public Law 108-173) had established the IPPE benefit and the framework for adding additional preventive services. The SAAAVE Act layered on top of this by adding a specific covered preventive service for a defined high-risk population.

Original IPPE Referral Requirement and Its Elimination

The original SAAAVE Act required that AAA ultrasound screening be referred during the Initial Preventive Physical Examination, which itself had to occur within 12 months of Medicare Part B enrollment. This requirement substantially limited the practical reach of the benefit because many beneficiaries did not complete an IPPE within the required window, and beneficiaries who developed eligibility risk factors later in life (for example, family history disclosure later, or aging into the 65 to 75 window after the 12-month IPPE window had passed) could not qualify.

Section 4103 of the Affordable Care Act (Public Law 111-148) addressed this barrier by eliminating the IPPE referral requirement for AAA screening effective January 1, 2011. After this date, the SAAAVE Act benefit became accessible through referral during the Annual Wellness Visit, during any clinical encounter, or through self-presentation with documentation of eligibility. This change substantially expanded the practical reach of the benefit, though the one-time-lifetime frequency limitation remains.

42 CFR 410.19 Implementing Regulations

The implementing regulations at 42 CFR 410.19 codify the SAAAVE Act framework. The regulations define:

The covered service as a procedure using ultrasound technology to screen for abdominal aortic aneurysm.
Eligible beneficiary criteria (family history or male ever-smoker 65 to 75).
Referral requirements (a physician, physician assistant, nurse practitioner, or clinical nurse specialist).
One-time-lifetime frequency.
Requirements for the supplier furnishing the screening (Medicare enrollment, qualified imaging supplier).

Section 4104 of the Affordable Care Act amended Section 1833(a) of the Social Security Act to eliminate the Part B deductible and coinsurance for "preventive services" defined as services with a USPSTF Grade A or B recommendation. Effective January 1, 2011, beneficiaries pay $0 for these services when furnished by a participating Medicare provider in alignment with USPSTF criteria.

The USPSTF assigns AAA screening different grades by sex and smoking status. The Grade B recommendation for men age 65 to 75 who have ever smoked aligns clearly with the ACA Section 4104 waiver, and these beneficiaries pay $0 for SAAAVE Act screening. For other eligible beneficiaries (for example, men with family history who have never smoked), Medicare contractor adjudication of cost-sharing alignment can be more nuanced because USPSTF Grade C does not automatically trigger the waiver. In practice, the Medicare Administrative Contractor processes the claim and applies cost-sharing based on the screening's alignment with USPSTF criteria as reflected in claim coding.

Part 2: Eligibility Criteria

The Two Pathways to Eligibility

Section 1861(bbb) defines two pathways to eligibility for the SAAAVE Act benefit:

Family history of AAA: A beneficiary who has a family history of abdominal aortic aneurysm. This is generally interpreted as a first-degree relative (parent, sibling, child) with documented AAA. There is no statutory upper or lower age limit for the family history pathway, though clinical practice typically focuses on the screening-relevant age range (generally 50 and older).
Male age 65 to 75 with lifetime smoking history of 100 or more cigarettes: A man within the 65 to 75 age window who has smoked at least 100 cigarettes in his lifetime. The 100-cigarette threshold is a clinical convention that essentially distinguishes any meaningful smoking history from never-smoker status.

A beneficiary needs to meet only one of the two pathways to be eligible.

Documentation of Eligibility

Eligibility documentation typically appears in the medical record as part of the referring clinician's note for the screening. The clinician documents either the family history (e.g., "father with AAA diagnosed and repaired") or the sex/age/smoking history (e.g., "70-year-old male with 30 pack-year smoking history, quit 5 years ago"). The Medicare claim for the screening (HCPCS G0389) is submitted with diagnosis coding supporting the eligibility pathway.

What Counts as "Family History"?

Medicare does not specify a precise definition of family history in the SAAAVE Act regulations. Clinical interpretation generally focuses on first-degree relatives with documented AAA. Some clinicians extend the consideration to second-degree relatives (grandparents, uncles, aunts) when the family history suggests a hereditary connective tissue disorder or substantial vascular disease pattern.

A few specific genetic conditions are associated with elevated AAA risk:

Marfan syndrome (FBN1 mutation).
Loeys-Dietz syndrome (TGFBR1, TGFBR2 mutations).
Ehlers-Danlos syndrome vascular type (COL3A1 mutation).
Familial thoracic aortic aneurysm and dissection (multiple genes).

Beneficiaries with these conditions or with strong family histories of vascular disease should be evaluated by vascular surgery or medical genetics for risk-stratified surveillance that may extend beyond the SAAAVE Act one-time benefit.

The Male Smoking History Pathway

The statutory pathway covers men age 65 to 75 with a lifetime smoking history of at least 100 cigarettes. The 100-cigarette threshold is essentially a clinical screen for ever-smoker status. The pack-year quantity is not specified by the statute, though USPSTF's underlying evidence base and Grade B recommendation focuses on current and former smokers as the highest-risk population. In practice, eligibility under this pathway is interpreted broadly: any history of smoking that exceeds the 100-cigarette threshold qualifies.

Why Women Are Not Specifically Covered

Section 1861(bbb)'s second eligibility pathway is sex-specific, covering only men. Women age 65 to 75 with smoking history qualify for the SAAAVE Act benefit only through the family history pathway (the first eligibility prong). This sex-specific framework reflects the USPSTF evidence base at the time of the SAAAVE Act, which showed AAA prevalence is substantially higher in men. Subsequent USPSTF updates have continued to give women a Grade I (insufficient evidence) for ever-smokers and a Grade D (recommend against) for never-smokers, supporting the statutory framework.

In clinical practice, individual women with substantial AAA risk factors (significant family history, ever-smoker status, hypertension, atherosclerotic disease) may receive ultrasound assessment under standard diagnostic coding rather than the SAAAVE Act benefit, with corresponding standard Part B cost-sharing applied.

Age Considerations

The male smoking-history pathway is bounded by age 65 to 75. A man younger than 65 does not qualify under this pathway through the SAAAVE Act, though clinical context may indicate diagnostic ultrasound. A man older than 75 also does not qualify under the smoking-history pathway, though clinical context (suspicion of AAA, surveillance after prior workup) may warrant diagnostic imaging.

The family history pathway has no statutory age boundary, though clinical practice typically focuses on screening-relevant ages.

Part 3: HCPCS Coding and Service Delivery

HCPCS G0389 — Ultrasound, B-scan and/or Real Time with Image Documentation; for Abdominal Aortic Aneurysm Screening

HCPCS G0389 is the specific code for SAAAVE Act abdominal aortic aneurysm screening. It distinguishes the SAAAVE Act screening from diagnostic abdominal ultrasound coding. The G0389 code is used once-per-lifetime per the SAAAVE Act frequency limitation, contrasted with diagnostic abdominal aorta ultrasound (CPT 76770, 76775) which may be used for diagnostic indications and follow-up surveillance.

The technical component (TC) of G0389 represents the ultrasound study performed at the imaging facility. The professional component (PC) represents the interpretation by the radiologist or other interpreting physician. The global code (no modifier) represents both components together.

Performing Provider and Facility Requirements

The SAAAVE Act AAA ultrasound screening must be furnished by a Medicare-enrolled supplier. Typical settings include:

Hospital outpatient radiology departments.
Independent diagnostic testing facilities (IDTFs).
Office-based ultrasound in radiology, vascular surgery, or cardiology practices that meet Medicare supplier standards.

The interpreting physician must be qualified to interpret abdominal ultrasound, typically a radiologist or a vascular surgeon with appropriate training and credentialing. Sonographers performing the technical component are typically registered diagnostic medical sonographers (RDMS) or registered vascular technologists (RVT).

The Ultrasound Technique

The screening abdominal aortic ultrasound examines the aorta from the diaphragm to the iliac bifurcation. The sonographer measures the maximum anterior-posterior (AP) and transverse diameters of the aorta in multiple positions (proximal, mid, and distal). The aorta is normally less than 3.0 cm in diameter. An aortic diameter of 3.0 cm or greater is the standard definition of AAA.

The examination also evaluates the iliac arteries and may identify iliac artery aneurysm. Visualization of the entire aorta may be limited by patient body habitus and overlying bowel gas, particularly in obese beneficiaries.

Documentation Requirements

The radiologist's interpretation includes:

Maximum aortic diameter at multiple locations.
Description of aortic morphology (saccular, fusiform).
Any associated findings (iliac aneurysm, thrombus, dissection).
Quality of the examination including limitations from body habitus or bowel gas.
Recommendation for follow-up if AAA is detected.

The interpretation supports clinical decision-making about surveillance frequency or referral for surgical evaluation.

ACA Section 4104 waives Part B deductible and coinsurance for services with a USPSTF Grade A or B recommendation. The USPSTF Grade B recommendation applies to men age 65 to 75 who have ever smoked. Beneficiaries qualifying for the SAAAVE Act benefit under the male smoking-history pathway in the 65 to 75 age window receive the screening at $0 cost-sharing when furnished by a participating Medicare provider.

For beneficiaries qualifying through the family history pathway, the cost-sharing alignment depends on USPSTF criteria interpretation. In practice, claims processed under HCPCS G0389 with appropriate eligibility documentation typically apply the Section 4104 waiver, but beneficiaries should confirm cost-sharing with their provider's billing office and review the Medicare Summary Notice for the claim.

What If the Screening Detects an AAA Requiring Diagnostic Workup?

If the SAAAVE Act ultrasound screening detects an AAA, subsequent diagnostic imaging and clinical evaluation are not part of the SAAAVE Act benefit and are subject to standard Part B cost-sharing. This includes:

Follow-up surveillance ultrasound (CPT 76770, 76775) for known aneurysms.
CT angiography of the abdomen and pelvis.
Vascular surgery consultation.
Pre-operative cardiac and pulmonary evaluation.
Endovascular aneurysm repair (EVAR) or open surgical repair.

Beneficiaries with Medicare Supplement (Medigap) policies may have all or most of the standard Part B cost-sharing covered by their supplemental insurance.

Dual Eligibility and Medicaid Coordination

Beneficiaries dually eligible for Medicare and Georgia Medicaid have Part B cost-sharing covered by Medicaid as the secondary payer for Medicare-covered services. For dually eligible beneficiaries, any cost-sharing on diagnostic follow-up or repair after screening is generally covered through the Medicaid wrap-around, depending on Medicaid plan structure.

Medicare Advantage

Medicare Advantage plans must cover the SAAAVE Act benefit at least as comprehensively as Original Medicare. Cost-sharing for the screening itself follows the ACA Section 4104 framework (typically $0 for in-network screening when USPSTF Grade B aligned). Plans may have specific provider network and referral requirements that beneficiaries should confirm with their plan.

Part 5: USPSTF Recommendation Framework

The Differentiated Grading Across Sex and Smoking Status

The USPSTF AAA screening recommendation provides different grades for distinct populations, reflecting the underlying evidence base:

Men age 65 to 75 who have ever smoked: Grade B. The USPSTF recommends one-time screening with ultrasonography. The Grade B reflects evidence of moderate net benefit from screening this population.
Men age 65 to 75 who have never smoked: Grade C. The USPSTF recommends offering screening selectively to this population, based on patient-specific factors and shared decision-making. The Grade C reflects evidence of small net benefit overall, with potential greater benefit for individuals with additional risk factors.
Women age 65 to 75 who have ever smoked: Grade I. The USPSTF concludes the current evidence is insufficient to assess the balance of benefits and harms.
Women who have never smoked: Grade D. The USPSTF recommends against screening, concluding that the potential harms outweigh the potential benefits in this population.

Why the Grade Differs

The Grade differentiation reflects underlying epidemiology. AAA prevalence is substantially higher in older male smokers than in other populations. The number-needed-to-screen to prevent one AAA-related death is substantially lower in the Grade B population, making the net benefit of screening clearer. In lower-prevalence populations (women, never-smoking men), the absolute number of detected aneurysms per beneficiary screened drops, while the false-positive rate and incidental finding rate (which can lead to additional testing) remains relatively stable, reducing the net benefit ratio.

Statutory Coverage Versus USPSTF Grade

The SAAAVE Act statutory coverage definition is broader than the USPSTF Grade B population. A man with family history but never smoking, or a beneficiary with family history of any age, qualifies under the statute even though USPSTF may not recommend universal screening. This is one of the relatively few areas where the Medicare benefit specifically covers screening for a population USPSTF does not give a Grade B recommendation.

The cost-sharing waiver under ACA Section 4104 generally aligns with USPSTF Grade A or B recommendations. Beneficiaries qualifying under the SAAAVE Act through family history (when USPSTF may give Grade C or I) may have cost-sharing applied depending on Medicare Administrative Contractor adjudication.

Part 6: AAA Pathophysiology, Natural History, and Detection

What Is an Abdominal Aortic Aneurysm?

An abdominal aortic aneurysm is a localized dilation of the abdominal aorta to 3.0 cm or larger in maximum diameter. The normal infrarenal aorta is generally 2.0 cm in diameter or less. AAA represents pathologic remodeling of the aortic wall driven by inflammation, oxidative stress, and degradation of elastin and collagen in the medial layer of the artery.

Most AAAs are infrarenal (below the renal arteries). Juxtarenal, suprarenal, and thoracoabdominal aortic aneurysms involve more complex anatomy with implications for surgical approach.

Risk Factors

Established AAA risk factors include:

Age: Risk increases substantially after age 65.
Male sex: Prevalence is approximately 4 to 6 times higher in men than women.
Smoking: The strongest modifiable risk factor. Current smokers have approximately 5 times the risk of never-smokers; former smokers have approximately 3 times the risk.
Family history: First-degree relative with AAA increases risk approximately 2-fold.
Hypertension.
Hyperlipidemia.
Atherosclerotic disease elsewhere (coronary, peripheral, carotid).
Connective tissue disorders (Marfan, Loeys-Dietz, Ehlers-Danlos vascular type).

Natural History

AAA is generally asymptomatic until rupture. Most aneurysms grow slowly, with average expansion rates correlated with current size:

3.0 to 3.9 cm: approximately 0.1 to 0.4 cm per year.
4.0 to 4.9 cm: approximately 0.3 to 0.5 cm per year.
5.0 to 5.9 cm: approximately 0.4 to 0.7 cm per year.
6.0 cm or larger: approximately 0.7 to 1.0 cm per year.

Smoking accelerates expansion. Diabetes appears to slow expansion modestly.

Rupture risk rises substantially with size:

Less than 5.0 cm: less than 1 percent per year.
5.0 to 5.9 cm: approximately 1 to 5 percent per year.
6.0 to 6.9 cm: approximately 5 to 15 percent per year.
7.0 cm or larger: approximately 20 to 50 percent per year.

Why Detection Matters

AAA rupture is catastrophic. The overall case-fatality rate including out-of-hospital deaths approaches 80 percent. Among patients who reach the hospital with ruptured AAA, in-hospital mortality remains approximately 30 to 50 percent depending on hemodynamic status at presentation and access to emergent endovascular or open surgical repair.

Elective repair of detected AAA at appropriate size thresholds carries 30-day mortality of approximately 1 to 2 percent for endovascular aneurysm repair (EVAR) and approximately 4 to 5 percent for open surgical repair. The dramatic mortality differential between elective repair (low single-digit percent) and emergent ruptured repair (40 to 50 percent or higher) is the central rationale for screening.

Surveillance Imaging

For aneurysms detected at less than 5.5 cm, surveillance imaging is the standard approach. Surveillance frequency varies by size:

3.0 to 3.9 cm: every 3 years.
4.0 to 4.9 cm: every 12 months.
5.0 to 5.4 cm: every 6 months.

Surveillance is typically performed with abdominal ultrasound (CPT 76770 or 76775) under standard diagnostic Part B coding and standard cost-sharing. Some practices use CT angiography for larger aneurysms or when ultrasound visualization is limited.

Indications for Repair

Standard indications for AAA repair include:

Aneurysm diameter 5.5 cm or larger in men.
Aneurysm diameter 5.0 cm or larger in women (lower threshold reflecting smaller baseline aortic diameter).
Rapid expansion (greater than 0.5 cm in 6 months or greater than 1.0 cm in 12 months).
Symptomatic aneurysm (abdominal or back pain attributed to aneurysm).
Ruptured or contained ruptured aneurysm (emergent).

Part 7: Repair Pathways

Endovascular Aneurysm Repair (EVAR)

EVAR is the predominant repair approach for elective AAA repair in current practice. The procedure involves:

Femoral artery access (typically bilateral).
Catheter-based delivery of a stent-graft into the aneurysm.
Deployment of the stent-graft to exclude the aneurysm sac from blood flow.
Sealing of the stent-graft at the proximal aortic neck and the distal iliac landing zones.

EVAR is performed in a hybrid operating room or vascular interventional suite. Hospital length of stay is typically 1 to 3 days. Recovery is substantially shorter than open repair.

EVAR is generally preferred for beneficiaries with favorable anatomy (adequate proximal aortic neck length and angulation, adequate iliac access), older beneficiaries, beneficiaries with significant comorbidities, and beneficiaries who prefer minimally invasive approaches.

Long-term follow-up after EVAR includes annual imaging (CT angiography or ultrasound) to monitor for endoleak (continued blood flow into the aneurysm sac around the stent-graft), aneurysm sac enlargement, stent-graft migration, and limb occlusion. Reintervention rates after EVAR over 5 to 10 years are approximately 15 to 25 percent.

Open Surgical Repair

Open surgical repair involves direct surgical replacement of the aneurysmal aortic segment with a synthetic graft (typically Dacron or polytetrafluoroethylene). The procedure involves:

Transabdominal or retroperitoneal approach.
Aortic clamping above and below the aneurysm.
Aneurysm sac opening.
Synthetic graft placement.
Closure of the aneurysm sac over the graft.

Open repair is performed under general anesthesia. Hospital length of stay is typically 5 to 10 days. Recovery extends over weeks to months.

Open repair is generally preferred for beneficiaries with anatomy unfavorable for EVAR, younger beneficiaries who may have decades of remaining life expectancy, and beneficiaries in whom long-term durability with minimal reintervention is prioritized. Long-term follow-up after open repair is less imaging-intensive than after EVAR.

Choice Between EVAR and Open Repair

The choice between EVAR and open repair depends on anatomic suitability, beneficiary age and life expectancy, comorbidities, and shared decision-making between the beneficiary and the vascular surgery team. Multidisciplinary evaluation including vascular surgery, anesthesiology, and cardiology pre-operative assessment supports the decision.

Part 8: Tobacco Cessation Coordination

Why Cessation Matters for AAA

Smoking is the strongest modifiable AAA risk factor. Smoking accelerates aneurysm expansion and increases rupture risk independent of size. For beneficiaries with detected small AAA who are current smokers, cessation is the single most important intervention to reduce the risk of progression to repair indication or rupture.

Medicare Tobacco Cessation Counseling

Section 1861(s)(2)(EE) of the Social Security Act authorizes Medicare coverage of tobacco cessation counseling for asymptomatic Medicare beneficiaries. Coverage includes:

HCPCS G0436: Smoking and tobacco-use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes.
HCPCS G0437: Smoking and tobacco-use cessation counseling visit; intensive, greater than 10 minutes.

Coverage allows 8 counseling sessions per 12-month period (two cessation attempts with four counseling visits each). ACA Section 4104 waives Part B cost-sharing for tobacco cessation counseling for asymptomatic users (USPSTF Grade A aligned).

Pharmacotherapy

Medicare Part D covers prescription smoking cessation medications including:

Varenicline (Chantix).
Bupropion sustained-release (Zyban).

Over-the-counter nicotine replacement therapy products (patches, gum, lozenges) are generally not covered by Part D as outpatient pharmacy benefits but may be available through other resources including the Georgia Tobacco Quit Line.

Georgia Tobacco Quit Line

The Georgia Tobacco Quit Line provides free telephone counseling and may provide nicotine replacement therapy in certain circumstances. The Quit Line is operated through the Georgia Department of Public Health Tobacco Use Prevention Section.

Phone: 1-877-270-7867 (1-877-270-STOP).

Part 9: Coordination With Annual Wellness Visit and IPPE

AWV Coordination

The Annual Wellness Visit under Section 1861(hhh) of the Social Security Act is the natural venue for AAA screening discussion and referral. The AWV health risk assessment captures smoking history and family history. The personalized prevention plan service developed during the AWV identifies and documents recommended preventive services, including AAA screening for beneficiaries who meet eligibility criteria and have not previously received the one-time screening.

Beneficiaries should be specifically asked about AAA screening eligibility during AWV encounters, particularly:

Male beneficiaries entering the 65 to 75 window.
Beneficiaries reporting smoking history.
Beneficiaries reporting family history of vascular disease.

IPPE Coordination

The Initial Preventive Physical Examination ("Welcome to Medicare" visit) under Section 1861(ww) is available within the first 12 months of Medicare Part B enrollment. The IPPE includes a health risk assessment, review of medical and family history, and identification of preventive service recommendations. AAA screening referral may originate during the IPPE for eligible beneficiaries.

The original SAAAVE Act required the referral to occur during the IPPE within the 12-month window. ACA Section 4103 eliminated this requirement effective January 1, 2011, but the IPPE remains an appropriate venue for AAA screening referral when the beneficiary completes an IPPE.

Part 10: The Georgia Vascular Surgery Landscape

Emory Vascular Surgery

Emory Healthcare operates a comprehensive vascular surgery program with locations across metro Atlanta. The Emory Aortic Center coordinates EVAR, open AAA repair, and complex aortic surgery. Emory's vascular surgery program is integrated with Emory cardiac surgery and Emory interventional radiology for multidisciplinary aortic care.

Wellstar Vascular Surgery

Wellstar Health System operates vascular surgery programs across north and west Georgia. Wellstar Kennestone Hospital and Wellstar West Georgia Medical Center serve as primary tertiary centers for vascular surgery in their respective regions. Wellstar vascular surgeons provide EVAR and open AAA repair.

Piedmont Heart Institute Vascular Surgery

Piedmont Healthcare's Heart Institute integrates vascular surgery with cardiac surgery and interventional cardiology. Piedmont vascular surgery operates across the Piedmont network in metro Atlanta and across Georgia, providing EVAR, open AAA repair, and aortic dissection management.

Northside Hospital Vascular Surgery

Northside Hospital operates vascular surgery programs across its north Atlanta network. Northside provides EVAR and open AAA repair with integration into Northside's cardiac surgery program.

Augusta University Vascular Surgery

Augusta University Health operates vascular surgery as an academic tertiary referral center for east Georgia. The Augusta vascular surgery program provides comprehensive aortic surgery including complex thoracoabdominal aneurysm repair.

Atrium Health Navicent Vascular Surgery

Atrium Health Navicent (Macon) operates vascular surgery as the central Georgia tertiary referral center. Navicent's vascular surgery program provides EVAR and open AAA repair, serving a large rural catchment in central and south Georgia.

Memorial Health Vascular Surgery (Savannah)

Memorial Health University Medical Center in Savannah operates vascular surgery serving coastal Georgia. Memorial provides EVAR and open AAA repair.

Phoebe Putney Vascular Surgery

Phoebe Putney Memorial Hospital (Albany) operates vascular surgery serving southwest Georgia, providing AAA repair within its rural catchment.

Rural Georgia Access Considerations

While Georgia's major metropolitan areas have comprehensive vascular surgery resources, rural Georgia counties may have limited local access. Beneficiaries in rural Georgia may receive their initial AAA ultrasound screening at a local hospital or radiology facility but require travel for vascular surgery consultation and repair when an aneurysm is detected at surgical thresholds. Telemedicine consultation is increasingly available through major Georgia vascular surgery programs.

Coordination of Care

Major Georgia vascular surgery programs offer multidisciplinary aortic surgery teams, hybrid operating rooms equipped for both endovascular and open procedures, vascular medicine integration, anesthesiology specialized in vascular cases, and post-operative care expertise. Beneficiaries with detected AAA should ask their primary care clinician about referral to a vascular surgery program with experience in EVAR and open AAA repair, particularly for aneurysms approaching or exceeding the 5.5 cm threshold.

Part 11: Best Practices for Beneficiaries and Clinicians

Identify eligibility during AWV or IPPE: Use the Annual Wellness Visit health risk assessment to capture smoking history and family history. Document AAA screening eligibility status for beneficiaries entering the 65 to 75 window.
Refer eligible beneficiaries who have not received the screening: The one-time-lifetime SAAAVE Act benefit can be claimed only once. Beneficiaries who have not received the screening and meet eligibility criteria should be referred without delay.
Confirm one-time-lifetime status: Before referring, confirm with the beneficiary and review prior records to determine whether SAAAVE Act screening has been previously performed. A repeated SAAAVE Act screening will be denied as a duplicate of the one-time-lifetime benefit, though diagnostic ultrasound for established AAA surveillance is separately covered under standard diagnostic coding.
Use HCPCS G0389 for the SAAAVE Act screening: The HCPCS G0389 code is specific to the SAAAVE Act benefit and distinguishes it from diagnostic ultrasound coding. Imaging facility billing staff should ensure G0389 is used with appropriate eligibility documentation.
Document eligibility pathway in the referral and the imaging record: The referring clinician's note and the radiologist's report should reflect the eligibility pathway (family history, or male age 65 to 75 ever-smoker). Documentation supports correct claim processing and ACA Section 4104 cost-sharing application.
Coordinate tobacco cessation referral: For beneficiaries who are current smokers, refer to Medicare-covered tobacco cessation counseling (G0436 or G0437) and to the Georgia Tobacco Quit Line. Pharmacotherapy referral for varenicline or bupropion may be appropriate.
Educate beneficiaries about the silent nature of AAA: Most AAAs are asymptomatic until rupture. The screening is valuable specifically because it detects aneurysms before they become symptomatic.
Establish surveillance plan for detected aneurysms: For aneurysms 3.0 to 5.4 cm, surveillance imaging at intervals based on size (3 years for 3.0 to 3.9 cm, annual for 4.0 to 4.9 cm, every 6 months for 5.0 to 5.4 cm) supports early identification of growth requiring repair.
Refer to vascular surgery for aneurysms approaching repair thresholds: Aneurysms 5.0 cm or larger in women, 5.5 cm or larger in men, rapidly expanding, or symptomatic warrant vascular surgery evaluation.
Use multidisciplinary aortic team for repair planning: Aortic surgery decision-making benefits from multidisciplinary input including vascular surgery, cardiology, anesthesiology, and patient shared decision-making about EVAR versus open repair.
Address cardiovascular risk factors comprehensively: Detected AAA is a marker for atherosclerotic disease elsewhere. Beneficiaries should have comprehensive cardiovascular risk assessment including statin therapy, blood pressure management, and aspirin where indicated.
Coordinate Medicare Advantage network access: Beneficiaries enrolled in Medicare Advantage should confirm in-network coverage for AAA screening and vascular surgery consultation.
Leverage GeorgiaCares SHIP for benefit navigation: GeorgiaCares (1-866-552-4464) provides free, unbiased Medicare benefit counseling and can help beneficiaries navigate the SAAAVE Act benefit and downstream care.
Plan for travel and care coordination from rural Georgia: Beneficiaries in rural Georgia counties may need to travel to metropolitan vascular surgery programs for repair. Plan ahead for transportation, accommodation, and family support.

Part 12: Common Issues and Resolutions

The SAAAVE Act screening was denied as not covered: Verify that the claim was submitted with HCPCS G0389, with appropriate eligibility documentation. If denied as not covered, review the Medicare Summary Notice for the denial reason and consider appeal with documentation of eligibility (family history documentation or smoking history with sex/age verification).
The screening was previously performed and a second is requested: The SAAAVE Act benefit is one-time-lifetime. A repeated SAAAVE Act screening will be denied. Diagnostic ultrasound for surveillance of detected AAA is separately covered under standard diagnostic coding (CPT 76770 or 76775).
A beneficiary is older than 75 and was never screened: The male smoking-history pathway is bounded by age 65 to 75. A beneficiary now older than 75 does not qualify under this pathway. The family history pathway has no statutory age boundary, so eligibility may still apply if the beneficiary has documented family history of AAA. Clinical diagnostic ultrasound for risk assessment may also be appropriate under standard coding.
A woman with significant smoking history wants screening: Women qualify for the SAAAVE Act benefit only through the family history pathway. A woman with smoking history but no family history does not qualify under the statutory framework. Clinical context and shared decision-making may support diagnostic ultrasound under standard coding.
Cost-sharing was applied despite eligibility: ACA Section 4104 waives cost-sharing for USPSTF Grade A or B aligned services. Beneficiaries meeting the Grade B definition (men 65 to 75 ever-smokers) should pay $0. If cost-sharing was applied, contact the Medicare Administrative Contractor (Palmetto GBA at 1-866-238-9650) for review.
The referring clinician is not a physician: The SAAAVE Act allows referral from a physician, physician assistant, nurse practitioner, or clinical nurse specialist. Referrals from licensed practitioners within these categories are accepted.
The imaging facility is not Medicare-enrolled: The SAAAVE Act screening must be furnished by a Medicare-enrolled supplier. Beneficiaries should verify Medicare enrollment with the imaging facility before scheduling to avoid coverage denials.
A small aneurysm was detected and the beneficiary is concerned about cost of surveillance: Surveillance imaging for detected AAA uses diagnostic ultrasound coding (CPT 76770 or 76775) and is subject to standard Part B cost-sharing. Medicare Supplement coverage or Medicaid (for dually eligible beneficiaries) may cover the cost-sharing.
The beneficiary received an AAA ultrasound before age 65: Pre-Medicare AAA imaging is not part of the Medicare SAAAVE Act benefit. The beneficiary may still qualify for the one-time SAAAVE Act benefit when they become Medicare-eligible if the pre-Medicare imaging is not a Medicare-billed SAAAVE Act G0389 claim.
EVAR or open repair surgery is recommended but the beneficiary lives in rural Georgia: Vascular surgery referral typically requires travel to a major metropolitan center. Coordinate with the vascular surgery program for logistics including pre-operative evaluation timing, hospital length of stay, post-operative follow-up, and transportation back to home community.
A beneficiary refuses the recommended repair: Beneficiaries have the right to refuse recommended procedures after informed discussion. Continued surveillance imaging and risk factor management (smoking cessation, blood pressure control) may slow progression. Documentation of informed refusal is important for the medical record.
The beneficiary is dually eligible and has cost-sharing concerns: Beneficiaries dually eligible for Medicare and Georgia Medicaid have Part B cost-sharing covered by Medicaid as the secondary payer. Confirm dual eligibility status with the DCH Medicaid Member Services (1-866-211-0950) and verify coordination with Medicare claims.
Concern about radiation exposure: AAA ultrasound screening uses no radiation. Subsequent diagnostic imaging using CT angiography does involve radiation exposure but is justified by the clinical indication when AAA is detected.
The screening shows a "borderline" aortic diameter of 2.8 to 2.9 cm: Diameters less than 3.0 cm do not meet the standard AAA definition. Some clinicians establish surveillance for borderline measurements given measurement variability and the relatively low cost of periodic re-imaging. Discussion with the primary care clinician and potentially a vascular medicine specialist supports the surveillance plan.

Part 13: Worked Examples

Example 1: Fulton County Male Age 66 Current Smoker With 30 Pack-Year History

A 66-year-old man living in Fulton County (Atlanta), enrolled in Original Medicare Part B for one year, has a 30 pack-year smoking history (1 pack per day for 30 years), continues to smoke approximately half a pack per day, and has hypertension. He is otherwise asymptomatic. During his Annual Wellness Visit at an Emory primary care practice, the AWV health risk assessment captures his smoking history, hypertension, and family history (no documented family history of AAA). The primary care physician identifies him as an eligible beneficiary under the SAAAVE Act male smoking-history pathway (age 65 to 75, lifetime smoking history exceeding 100 cigarettes).

The physician refers the patient for AAA ultrasound screening at Emory Radiology and provides counseling about smoking cessation with referral to a Medicare tobacco cessation counseling visit (G0437) and to the Georgia Tobacco Quit Line. The Emory Radiology AAA ultrasound is performed and billed under HCPCS G0389. The radiologist's interpretation shows aortic diameter of 2.6 cm proximal, 2.5 cm mid, 2.4 cm distal — within normal limits and below the 3.0 cm AAA threshold.

The beneficiary pays $0 for the screening under the ACA Section 4104 cost-sharing waiver because he meets the USPSTF Grade B criteria (man age 65 to 75 ever-smoker). The radiologist's report notes that no AAA is detected; routine clinical follow-up at the discretion of the primary care physician is recommended, with no specific recommendation for repeat surveillance imaging at the present time. The beneficiary completes the SAAAVE Act one-time-lifetime benefit. He completes four tobacco cessation counseling sessions over the next 6 months and successfully quits smoking with the support of varenicline (covered by his Medicare Part D plan).

Example 2: Worth County Male Age 72 Strong Family History of AAA, Rural Georgia Access

A 72-year-old man living in Worth County (rural southwest Georgia), enrolled in Original Medicare Part B for seven years, has never smoked. His father died of ruptured AAA at age 78 and his older brother required open AAA repair at age 70. He had not previously been screened for AAA. During a routine visit with his primary care provider at a Federally Qualified Health Center in Worth County, he reports his family history. The primary care provider identifies him as eligible under the SAAAVE Act family history pathway (he has not yet received the one-time-lifetime benefit).

The primary care provider refers him to Phoebe Putney Memorial Hospital (Albany, approximately 30 miles east) for AAA ultrasound screening. The Phoebe Putney Radiology AAA ultrasound is performed and billed under HCPCS G0389 with diagnosis code documenting family history of AAA. The radiologist's interpretation shows aortic diameter of 4.2 cm at the maximum infrarenal measurement, consistent with AAA.

The patient is referred to Phoebe Putney Vascular Surgery for evaluation. The vascular surgeon discusses surveillance imaging given the size below the 5.5 cm repair threshold, with annual ultrasound surveillance under standard diagnostic ultrasound coding. The vascular surgeon counsels on cardiovascular risk factor management, including initiation of statin therapy, low-dose aspirin (after discussion of bleeding risk), and continued blood pressure management. The patient pays $0 for the SAAAVE Act screening under the cost-sharing waiver applied to his claim. Surveillance ultrasounds will be subject to standard Part B cost-sharing. The patient has a Medicare Supplement Plan G that will cover the standard Part B coinsurance for the surveillance imaging.

Example 3: Cobb County Detection of 5.8 cm Aneurysm — Wellstar EVAR Referral

A 69-year-old man living in Cobb County, enrolled in Medicare Advantage (Wellstar Total Care HMO), has a 40 pack-year smoking history (quit 5 years ago), known hypertension, and known peripheral artery disease. During his Annual Wellness Visit at a Wellstar primary care practice, his physician identifies that he is eligible for the SAAAVE Act benefit and has not yet been screened. The physician refers him for AAA ultrasound screening at Wellstar Kennestone Radiology.

The AAA ultrasound is performed under HCPCS G0389. The radiologist's interpretation shows infrarenal aortic diameter of 5.8 cm — above the 5.5 cm threshold for repair indication in men. The patient is urgently referred to Wellstar Vascular Surgery at Wellstar Kennestone Hospital for evaluation.

Wellstar Vascular Surgery performs comprehensive pre-operative evaluation including CT angiography of the abdomen and pelvis to define the anatomy for EVAR planning. The CT angiography confirms a 5.9 cm infrarenal AAA with a 25 mm proximal aortic neck length and adequate iliac landing zones for EVAR. Cardiac evaluation includes a stress echocardiogram showing no significant ischemia. Pulmonary function testing shows mild obstructive disease consistent with prior smoking but adequate for the planned procedure.

The patient elects EVAR after multidisciplinary discussion. The procedure is performed at Wellstar Kennestone Hybrid Operating Room with bilateral percutaneous femoral access. The procedure is uncomplicated with placement of a bifurcated aortic stent-graft. Hospital length of stay is 2 days. Post-operative imaging at 30 days, 6 months, and annually thereafter shows successful aneurysm exclusion without endoleak. The SAAAVE Act screening cost-sharing was $0; the EVAR procedure and subsequent surveillance are subject to standard Medicare Advantage cost-sharing under the plan structure.

Example 4: Bibb County Female Age 68 Ever-Smoker With Family History — Eligibility Through Family History Pathway

A 68-year-old woman living in Bibb County (Macon), enrolled in Original Medicare Part B for three years, has a 20 pack-year smoking history (current smoker), known hypertension, and her mother had a documented AAA (4.5 cm at last surveillance imaging, age 80 at her death from unrelated causes). The patient asks her primary care provider about AAA screening based on her mother's history.

The primary care provider identifies her as eligible under the SAAAVE Act family history pathway (the male smoking-history pathway does not apply to women). The primary care provider refers her to Atrium Health Navicent Radiology for AAA ultrasound screening under HCPCS G0389. The interpretation shows aortic diameter of 3.4 cm at maximum infrarenal measurement, consistent with small AAA.

The patient is referred to Atrium Health Navicent Vascular Surgery for evaluation. The vascular surgeon recommends annual surveillance ultrasound imaging given the size below repair thresholds. The surgeon strongly counsels smoking cessation, given that smoking is the strongest modifiable risk factor for AAA expansion. The patient is referred for Medicare-covered tobacco cessation counseling (G0437 four sessions) and to the Georgia Tobacco Quit Line.

For cost-sharing, the SAAAVE Act claim was processed with $0 cost-sharing application. The patient's eligibility was through the family history pathway; the USPSTF Grade I assignment for women ever-smokers does not automatically trigger the ACA Section 4104 waiver, but in this case the claim was processed without cost-sharing application. Surveillance ultrasounds in subsequent years will be subject to standard Part B cost-sharing (20 percent coinsurance after the Part B deductible). The patient's Medicare Supplement Plan F covers her standard Part B cost-sharing.

Example 5: DeKalb County Beneficiary Age 76 — Outside the Smoking-Pathway Age Window

A 76-year-old man living in DeKalb County, enrolled in Original Medicare Part B for eleven years, has a 35 pack-year smoking history (quit 10 years ago), known coronary artery disease (prior coronary stenting), and known peripheral artery disease. He has never been screened for AAA. He asks his primary care physician at Emory Decatur whether he is eligible for AAA screening.

The primary care physician explains that the SAAAVE Act male smoking-history pathway is bounded by age 65 to 75. At age 76, the patient is outside the pathway. The patient does not have documented family history of AAA. Therefore, the patient does not qualify for the SAAAVE Act benefit under either statutory pathway.

The primary care physician explains that clinical diagnostic ultrasound of the abdominal aorta is appropriate under standard diagnostic coding given his cardiovascular risk profile. The diagnostic ultrasound is performed at Emory Radiology under CPT 76770 with standard Part B cost-sharing (Part B deductible if not previously met, plus 20 percent coinsurance on the Medicare-approved amount). The patient's Medicare Supplement Plan G covers the coinsurance.

The diagnostic ultrasound shows aortic diameter of 4.4 cm, consistent with AAA. The patient is referred to Emory Vascular Surgery for evaluation and annual surveillance imaging plan. The case illustrates that age windows in the SAAAVE Act statute may exclude high-risk beneficiaries who would benefit clinically from AAA evaluation; standard diagnostic coding provides an alternative coverage pathway with standard cost-sharing.

Example 6: Cherokee County Tobacco Cessation Coordination During AAA Screening Workflow

A 67-year-old man living in Cherokee County, enrolled in Original Medicare Part B for two years, has a 35 pack-year smoking history, currently smokes 1 pack per day, and has hypertension. During his Annual Wellness Visit at a Piedmont primary care practice, his physician identifies him as eligible for the SAAAVE Act benefit. The physician refers him to Piedmont Radiology for AAA ultrasound screening under HCPCS G0389 and concurrently refers him for Medicare-covered tobacco cessation counseling.

The AAA ultrasound shows aortic diameter of 3.2 cm — small AAA above the 3.0 cm definitional threshold. The patient is referred to Piedmont Heart Institute Vascular Surgery for evaluation and surveillance plan. The vascular surgeon establishes a surveillance plan of repeat ultrasound at 3 years (interval appropriate for 3.0 to 3.9 cm aneurysm) and emphasizes that smoking cessation is the single most important intervention to slow aneurysm progression.

The patient completes Medicare-covered tobacco cessation counseling sessions (8 sessions over 12 months under HCPCS G0436 and G0437 across two cessation attempts), uses varenicline covered by his Medicare Part D plan, and connects with the Georgia Tobacco Quit Line for additional support. He successfully quits smoking after the second cessation attempt. At his 3-year surveillance ultrasound, his aneurysm measures 3.3 cm — minimal expansion, consistent with the slower progression rate after smoking cessation. The case illustrates the integration of AAA screening with comprehensive tobacco cessation coordination — the SAAAVE Act screening identifies the aneurysm, and the cessation intervention substantially reduces the long-term progression risk.

Part 14: Frequently Asked Questions

What is the Medicare AAA screening benefit?

What does SAAAVE Act mean?

SAAAVE stands for "Screening Abdominal Aortic Aneurysms Very Efficiently." It is the common name for Section 5112 of the Deficit Reduction Act of 2005 (Public Law 109-171), signed February 8, 2006, which established the Medicare AAA screening benefit.

Who is eligible for the SAAAVE Act AAA screening?

Two pathways: (1) a beneficiary with a family history of abdominal aortic aneurysm, or (2) a man age 65 to 75 who has smoked at least 100 cigarettes in his lifetime. A beneficiary needs to meet only one of the two pathways.

How often can I have the SAAAVE Act AAA screening?

The SAAAVE Act benefit is once per lifetime. A beneficiary who has received a Medicare-covered SAAAVE Act screening (HCPCS G0389) is not eligible for an additional one through this benefit.

What is the HCPCS code for AAA screening?

HCPCS G0389 is the specific code for SAAAVE Act AAA ultrasound screening. It distinguishes the SAAAVE Act benefit from diagnostic abdominal ultrasound coding.

Do I need a referral?

Yes. Section 1861(bbb) requires referral from a physician, physician assistant, nurse practitioner, or clinical nurse specialist. The referral documents the beneficiary's eligibility under one of the two pathways.

What was the original IPPE referral requirement?

The original SAAAVE Act required referral during the Initial Preventive Physical Examination ("Welcome to Medicare" visit) within 12 months of Medicare Part B enrollment. Affordable Care Act Section 4103 eliminated this IPPE-specific referral requirement effective January 1, 2011.

What does the AAA screening cost?

For beneficiaries qualifying under the male smoking-history pathway (USPSTF Grade B), the screening is $0 under the Affordable Care Act Section 4104 cost-sharing waiver. For beneficiaries qualifying under the family history pathway, cost-sharing depends on Medicare Administrative Contractor adjudication and USPSTF criteria alignment.

What does the AAA screening involve?

The screening is an ultrasound examination of the abdominal aorta. The sonographer measures the maximum diameter of the aorta at multiple positions. The interpretation by a radiologist identifies whether the aorta is enlarged (3.0 cm or greater is the AAA definition) and characterizes any associated findings.

What is the normal aortic size?

The normal infrarenal abdominal aorta is generally less than 2.0 cm in diameter. An aortic diameter of 3.0 cm or greater is the standard AAA definition.

What if the screening detects an AAA?

If the screening detects an AAA, subsequent care depends on the aneurysm size: aneurysms 3.0 to 5.4 cm typically undergo surveillance imaging at intervals based on size; aneurysms 5.5 cm or larger in men, 5.0 cm or larger in women, rapidly expanding, or symptomatic typically warrant referral for surgical or endovascular repair.

What is the risk of AAA rupture?

Rupture risk rises substantially with aneurysm size: less than 5.0 cm carries less than 1 percent annual risk; 5.0 to 5.9 cm approximately 1 to 5 percent; 6.0 to 6.9 cm approximately 5 to 15 percent; 7.0 cm or larger approximately 20 to 50 percent. Rupture is catastrophic with overall case-fatality approaching 80 percent including out-of-hospital deaths.

What is EVAR?

EVAR stands for Endovascular Aneurysm Repair. The procedure involves catheter-based placement of a stent-graft into the aneurysm through femoral artery access. EVAR has shorter recovery, lower 30-day mortality, and requires lifelong imaging surveillance after repair.

What is open AAA repair?

Open AAA repair is a surgical procedure involving direct replacement of the aneurysmal aortic segment with a synthetic graft. Open repair has longer recovery, higher 30-day mortality than EVAR, and requires less intensive long-term surveillance.

How does smoking affect AAA risk?

Smoking is the strongest modifiable AAA risk factor. Current smokers have approximately 5 times the AAA risk of never-smokers; former smokers have approximately 3 times the risk. Smoking accelerates aneurysm expansion and increases rupture risk. Cessation is the most important intervention for beneficiaries with detected small AAA.

Why are women not specifically covered under the male smoking-history pathway?

Section 1861(bbb) defines the male smoking-history pathway as sex-specific. This reflects the underlying epidemiology — AAA prevalence is approximately 4 to 6 times higher in men than women — and the USPSTF evidence base. Women qualify for the SAAAVE Act benefit through the family history pathway.

What does USPSTF say about AAA screening?

USPSTF gives differential grades: Grade B for men 65 to 75 who have ever smoked; Grade C for men 65 to 75 never-smokers (selective offering); Grade I (insufficient evidence) for women 65 to 75 ever-smokers; Grade D (recommend against) for women never-smokers.

What if I'm older than 75?

The male smoking-history pathway is bounded by age 65 to 75. A man older than 75 does not qualify under this pathway. The family history pathway has no statutory age boundary, so eligibility may still apply if the beneficiary has documented family history. Clinical diagnostic ultrasound may be appropriate under standard coding for clinical indication.

What if I had a non-Medicare AAA ultrasound before age 65?

Pre-Medicare AAA imaging is not part of the Medicare SAAAVE Act benefit. The beneficiary may still qualify for the one-time SAAAVE Act benefit when becoming Medicare-eligible.

Does Medicare Advantage cover the AAA screening?

Yes. Medicare Advantage plans must cover the SAAAVE Act benefit at least as comprehensively as Original Medicare. Cost-sharing for the screening typically follows the ACA Section 4104 framework ($0 for USPSTF Grade B aligned screening). Plans may have specific network and referral requirements.

Does Georgia Medicaid coordinate with the SAAAVE Act benefit?

For dually eligible beneficiaries (Medicare and Georgia Medicaid), Medicaid covers Part B cost-sharing as the secondary payer. Any cost-sharing applied to the SAAAVE Act screening or downstream care is generally covered through the Medicaid wrap-around, depending on plan structure.

Can the AAA screening be done at the same visit as my Annual Wellness Visit?

The AAA ultrasound is typically performed at a radiology facility, separate from the primary care AWV encounter. The AWV is a good venue for AAA screening referral, but the ultrasound itself is scheduled at the imaging facility.

Where in Georgia can I get AAA screening?

AAA ultrasound screening is available at Medicare-enrolled imaging facilities throughout Georgia including hospital outpatient radiology departments and independent diagnostic testing facilities. Major Georgia vascular surgery programs at Emory, Wellstar, Piedmont, Northside, Augusta University, Atrium Health Navicent, Memorial Health, and Phoebe Putney provide both screening and downstream evaluation.

How do I find a vascular surgeon in Georgia?

Major Georgia vascular surgery programs include Emory Vascular Surgery, Wellstar Vascular Surgery, Piedmont Heart Institute Vascular Surgery, Northside Hospital Vascular Surgery, Augusta University Vascular Surgery, Atrium Health Navicent Vascular Surgery, Memorial Health Vascular Surgery, and Phoebe Putney Vascular Surgery. Your primary care physician can refer you, or you can search the Medicare physician finder tool at Medicare.gov.

What if my screening shows a borderline result?

Aortic diameters less than 3.0 cm do not meet the standard AAA definition. Some clinicians establish surveillance for borderline measurements (2.5 to 2.9 cm) given measurement variability and the relatively low cost of periodic re-imaging. Discuss the appropriate plan with your primary care physician.

How do I get help understanding my Medicare AAA screening coverage?

Contact GeorgiaCares SHIP at 1-866-552-4464 for free, unbiased Medicare counseling. You can also call 1-800-MEDICARE or contact Palmetto GBA (the Medicare Administrative Contractor for Georgia) at 1-866-238-9650 with specific claim questions.

Resources and Contacts

For questions about the Medicare AAA Screening benefit, eligibility, claim processing, vascular surgery resources, or tobacco cessation in Georgia, the following resources can help:

Medicare: 1-800-MEDICARE (1-800-633-4227). General Medicare benefit questions, eligibility verification, claim status.
Palmetto GBA Medicare Administrative Contractor for Georgia: 1-866-238-9650. AAA screening claim adjudication, coverage clarifications.
Georgia DCH Medicaid Member Services: 1-866-211-0950. Medicaid eligibility for dually eligible beneficiaries, coordination of benefits.
GeorgiaCares SHIP: 1-866-552-4464. Free Medicare counseling including SAAAVE Act benefit navigation.
Medicare Rights Center: 1-800-333-4114. Beneficiary advocacy and education.
Atlanta Legal Aid Society: 404-377-0701. Free legal assistance for Medicare/Medicaid issues, low-income beneficiaries metro Atlanta.
Georgia Legal Services Program: 1-800-498-9469. Free legal assistance outside metro Atlanta.
211 Georgia: 211. Social service navigation, transportation assistance for medical appointments.
Eldercare Locator: 1-800-677-1116. Local Area Agency on Aging services across Georgia.
Georgia Department of Public Health: 404-657-2700. Tobacco use prevention coordination, AAA disease surveillance.
Society for Vascular Surgery: Vascular surgeon directory, beneficiary education materials.
American Heart Association: 1-800-242-8721. Cardiovascular disease education including AAA.
Vascular Disease Foundation / Vascular Cures: Vascular disease patient resources.
Georgia Tobacco Quit Line: 1-877-270-7867 (1-877-270-STOP). Free tobacco cessation counseling.
Emory Vascular Surgery: Atlanta academic medical center vascular surgery for AAA evaluation and repair.
Wellstar Vascular Surgery: North and west Georgia regional vascular surgery network.
Piedmont Heart Institute Vascular Surgery: Metro Atlanta and statewide network.
Acentra Health Beneficiary and Family Centered Care Quality Improvement Organization: 1-844-455-8708. Quality concerns and appeals.

Lung cancer screening, the AWV, the IPPE, and AAA screening are all part of Medicare's preventive services framework. Eligible Georgia beneficiaries should use the SAAAVE Act one-time benefit to detect a potentially catastrophic vascular condition while it remains treatable through elective EVAR or open repair, before progression to rupture.